- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds | 2 | Seeking Alpha | ||
| Fr | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds | 1 | GlobeNewswire (USA) | ||
| 16.12.25 | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan | 2 | GlobeNewswire (USA) | ||
| 15.12.25 | Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST | 1 | GlobeNewswire (USA) | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 05.12.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans | 1 | Seeking Alpha | ||
| 19.11.25 | Vivos Therapeutics GAAP EPS of -$0.49, revenue of $6.8M | 4 | Seeking Alpha | ||
| 19.11.25 | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 | 341 | GlobeNewswire (Europe) | Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference... ► Artikel lesen | |
| 19.11.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.11.25 | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11.25 | Vivos Therapeutics, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 04.11.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.10.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09.25 | Vivos Therapeutics, Inc: Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device | 240 | GlobeNewswire (Europe) | LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development... ► Artikel lesen | |
| 17.09.25 | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment | 211 | GlobeNewswire (Europe) | LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and technology company specializing in the development... ► Artikel lesen | |
| 12.09.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.08.25 | Vivos Therapeutics GAAP EPS of -$0.55, revenue of $3.82M | 3 | Seeking Alpha | ||
| 19.08.25 | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update | 263 | GlobeNewswire (Europe) | Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos' differentiated array of highly effective OSA treatments... ► Artikel lesen |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,380 | +1,24 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler präsentiert auf der 44. Annual J.P. Morgan Healthcare Conference | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Konferenz
Eckert & Ziegler präsentiert auf der 44. Annual J.P. Morgan Healthcare Conference
12.01.2026 / 14:56 CET/CEST
Für... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,100 | +2,05 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,018 | -7,37 % | NuGen Medical Devices Inc.: NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress | Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,288 | +3,12 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| CARDINAL HEALTH | 184,80 | +0,90 % | Cardinal Health Lifts FY26 Adj. Earnings View Above Market | WASHINGTON (dpa-AFX) - Cardinal Health Inc. (CAH), a distributor of pharmaceuticals and specialty products, on Tuesday lifted its fiscal 2026 adjusted earnings outlook again, driven by strong... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,525 | -1,50 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy | Designation further supports (Z)-Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pediatric Disease Designation
SEATTLE... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,110 | +2,80 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| VENUS CONCEPT | 7,940 | +455,24 % | Venus Concept Stock Explodes Over 500% After Major Investor Takes Control | ||
| FRESENIUS MEDICAL CARE | 37,470 | +1,88 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
| FRESENIUS | 49,830 | +0,36 % | DAX-Check LIVE: Commerzbank, Fresenius, Jost Werke, Nordex, Symrise, TKMS, Volkswagen Vz., Zalando | Der DAX ist mit weiteren Rekorden in die neue Woche gestartet und hat erstmals die Marke von 25.400 Punkten überschritten. Im Tageshoch erreichte der Leitindex 25.421 Punkte und markierte damit den... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 22,500 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,300 | -1,07 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 52,90 Euro belassen. 2025 sei ein schlechtes Jahr... ► Artikel lesen | |
| GENEDX | 108,08 | -1,10 % | Sema4.ai: Interview With Co-Founder & CEO Rob Bearden About The Enterprise AI Agent Platform |
VIVOS THERAPEUTICS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -3,50 % bei einem Aktienkurs von 2,065 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.